Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART
NCT00202618Phase 4Unknown
- Sponsor
- Shiga University
- Start
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Microalbuminuria, hypertension (HTN) and type 2 diabetes mellitus (T2DM) comparing Amlodipine with Valsartan (2 arms). Primary endpoints: Change in the rate of urinary albumin excretion at 24 weeks, Normalization of microalbuminuria at 24 weeks and 1 more. Status: unknown.
02
Drugs
valsartanamlodipine
03
Conditions
Microalbuminuriahypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00202618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202618.